Crossmark

An assessment of the prescribing preferences of Irish dermatology consultants for the treatment of severe psoriasis in the setting of a cancer diagnosis

Crossref DOI link: https://doi.org/10.1007/s11845-025-04113-0

Published Online: 2025-10-01

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bowe, Stephanie https://orcid.org/0000-0002-4958-820X
Murphy, Michelle

Bourke, John

Ryan, Caitriona
License Information

Text and Data Mining valid from 2025-10-01

Version of Record valid from 2025-10-01
More Information

Article History

Received: 11 August 2025

Accepted: 23 September 2025

First Online: 1 October 2025

Declarations

:

: Reviewed and approved by Clinical Research Ethics Committee (CREC).CREC Review Reference Number: ECM 4 (q) 05/12/2023.

: Dr. Stephanie Bowe, Prof. Michelle Murphy and Dr. John Bourke have no conflicts of interest. Prof. Ryan has received honoraria for serving on advisory boards, as a speaker, or as a consultant from AbbVie, Allergan, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Regeneron-Sanofi and UCB.

Document is current

Any future updates will be listed below